Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer

R. T. Eagan, S. Frytak, W. C. Nichols, J. N. Ingle, E. T. Creagan, L. K. Kvols, D. T. Coles

Research output: Contribution to journalArticle

9 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)715-717
Number of pages3
JournalCancer Treatment Reports
Volume65
Issue number7-8
StatePublished - 1981
Externally publishedYes

Fingerprint

Drug Administration Schedule
Drug Evaluation
Etoposide
Combination Drug Therapy
Palliative Care
Antineoplastic Agents
Doxorubicin
Cyclophosphamide
Cisplatin
Lung Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Eagan, R. T., Frytak, S., Nichols, W. C., Ingle, J. N., Creagan, E. T., Kvols, L. K., & Coles, D. T. (1981). Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer. Cancer Treatment Reports, 65(7-8), 715-717.

Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer. / Eagan, R. T.; Frytak, S.; Nichols, W. C.; Ingle, J. N.; Creagan, E. T.; Kvols, L. K.; Coles, D. T.

In: Cancer Treatment Reports, Vol. 65, No. 7-8, 1981, p. 715-717.

Research output: Contribution to journalArticle

Eagan, RT, Frytak, S, Nichols, WC, Ingle, JN, Creagan, ET, Kvols, LK & Coles, DT 1981, 'Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer', Cancer Treatment Reports, vol. 65, no. 7-8, pp. 715-717.
Eagan RT, Frytak S, Nichols WC, Ingle JN, Creagan ET, Kvols LK et al. Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer. Cancer Treatment Reports. 1981;65(7-8):715-717.
Eagan, R. T. ; Frytak, S. ; Nichols, W. C. ; Ingle, J. N. ; Creagan, E. T. ; Kvols, L. K. ; Coles, D. T. / Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer. In: Cancer Treatment Reports. 1981 ; Vol. 65, No. 7-8. pp. 715-717.
@article{1628ad3558864511a80d37e0ed8d3c96,
title = "Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer",
author = "Eagan, {R. T.} and S. Frytak and Nichols, {W. C.} and Ingle, {J. N.} and Creagan, {E. T.} and Kvols, {L. K.} and Coles, {D. T.}",
year = "1981",
language = "English (US)",
volume = "65",
pages = "715--717",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "7-8",

}

TY - JOUR

T1 - Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer

AU - Eagan, R. T.

AU - Frytak, S.

AU - Nichols, W. C.

AU - Ingle, J. N.

AU - Creagan, E. T.

AU - Kvols, L. K.

AU - Coles, D. T.

PY - 1981

Y1 - 1981

UR - http://www.scopus.com/inward/record.url?scp=0019454485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019454485&partnerID=8YFLogxK

M3 - Article

C2 - 6166376

AN - SCOPUS:0019454485

VL - 65

SP - 715

EP - 717

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 7-8

ER -